AFC-TAB-452CQ

antibody from Creative Biolabs

Targeting: TNFRSF4 ACT35, CD134, OX40, TXGP1L

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Immunoprecipitation (Recommended by provider)

Immunohistochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

AFC-TAB-452CQ

Provider

Creative Biolabs

Product name

Afuco? Anti-TNFRSF4 ADCC Recombinant Antibody (Tavolixizumab), ADCC Enhanced

Antibody type

Monoclonal

Description

This product is an ADCC enhanced antibody produced by our Afuco? platform. Recombinant monoclonal antibody to TNFRSF4. Tavolixizumab is a humanized and chimeric monoclonal antibody that can be potentially used in the treatment of Advanced Solid Tumors.

Reactivity

Human

Host

Human

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

Tavolixizumab

Storage

Store at +4¡ãC short term (1-2 weeks). Aliquot and store at -20¡ãC long term. Avoid repeated freeze/thaw cycles.